Facial Plast Surg 2019; 35(05): 540-545
DOI: 10.1055/s-0039-1693133
Original Research
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Perspectives of Facial Plastic Surgeons on Opioid Dependence in Rhinoplasty Patients

1   McMaster University Michael G. DeGroote School of Medicine, Medicine, Hamilton, Ontario, Canada
,
Michael G. Roskies
2   FACE Toronto, Toronto, Ontario, Canada
3   Department of Otolaryngology - Head and Neck Surgery, Division of Facial Plastic and Reconstructive Surgery, University of Toronto, Toronto, Ontario, Canada
,
Jamil Asaria
2   FACE Toronto, Toronto, Ontario, Canada
3   Department of Otolaryngology - Head and Neck Surgery, Division of Facial Plastic and Reconstructive Surgery, University of Toronto, Toronto, Ontario, Canada
› Author Affiliations
Further Information

Publication History

Publication Date:
10 July 2019 (online)

Abstract

Understanding the perspectives and opinions of facial plastic surgeons on opioid dependence is critical in a national epidemic of opioid overuse. Findings may encourage surgeon education so that facial plastic surgeons may be able to judiciously prescribe opioids, improving patient outcomes and reducing healthcare opioid-related spending. The objective of this study is to understand facial plastic surgeons' perspectives on opioid dependence in rhinoplasty patients. A key secondary objective was to quantify facial plastic surgeons' opioid prescribing patterns. This was a prospective survey study. A nine-question survey was sent to all members of the American Academy of Facial Plastic and Reconstructive Surgery in July of 2018, and analysis of the data was completed in August of 2018. The primary study outcome measurement was surgeon perspectives on opioid dependence. This was measured by an online survey. A total of 164 facial plastic surgeons responded to the survey (response rate: 6.6%). The majority were experienced surgeons in practice for more than 10 years (61.96%) who perform less than five rhinoplasties per week (84.15%). Of the facial plastic surgeons, 89.51% prescribe some variation of opioids following rhinoplasty. Most surgeons believe that opioid dependence is not a problem in rhinoplasty patients (86.96%), but that it is a problem among surgical patients in general (61.11%). The majority (52.45%) of surgeons prescribe between 11 and 25 tablets of opioids following rhinoplasty, with 25.17% of surgeons prescribing > 25 tablets of opioids. Facial plastic surgeons do not believe opioid dependence to be a problem among rhinoplasty patients. Resultantly, many facial plastic surgeons can prescribe more than 25 tables of opioids following rhinoplasty. The findings suggest that facial plastic surgeons may require further education and complete more research regarding opioid dependence among the rhinoplasty population. Additionally, the findings are important for health policy in that they encourage the creation of rhinoplasty specific opioid prescription guidelines.

 
  • References

  • 1 American Society of Plastic Surgeons. 2017 Plastic Surgery Statistics Report. Available at: https://www.plasticsurgery.org/documents/News/Statistics/2017/plastic-surgery-statistics-full-report-2017.pdf . Accessed August 29, 2018
  • 2 Patel S, Sturm A, Bobian M, Svider PF, Zuliani G, Kridel R. Opioid use by patients after rhinoplasty. JAMA Facial Plast Surg 2018; 20 (01) 24-30
  • 3 Schwartz MA, Naples JG, Kuo C-L, Falcone TE. Opioid prescribing patterns among otolaryngologists. Otolaryngol Head Neck Surg 2018; 158 (05) 854-859
  • 4 Sethi RKV, Lee LN, Quatela OE, Richburg KG, Shaye DA. Opioid prescription patterns after rhinoplasty. JAMA Facial Plast Surg 2019; 21 (01) 76-77
  • 5 Chou R, Gordon DB, de Leon-Casasola OA. , et al. Management of postoperative pain: a clinical practice guideline from the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative Council. J Pain 2016; 17 (02) 131-157
  • 6 Hill MV, Stucke RS, Mcmahon ML, Beeman JL, Jr RJr. An educational intervention decreases opioid prescribing after general surgical operations. 2017; 267 (03) 468-472
  • 7 Meisenberg BR, Grover J, Campbell C, Korpon D. Assessment of opioid prescribing practices before and after implementation of a health system intervention to reduce opioid overprescribing. JAMA Netw Open 2018; 1 (05) e182908
  • 8 Stanek JJ, Renslow MA, Kalliainen LK. The effect of an educational program on opioid prescription patterns in hand surgery: a quality improvement program. J Hand Surg Am 2015; 40 (02) 341-346
  • 9 Menendez ME, Mellema JJ, Ring D. Attitudes and self-reported practices of hand surgeons regarding prescription opioid use. Hand (N Y) 2015; 10 (04) 789-795
  • 10 World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2013; 310 (20) 2191-2194
  • 11 Makary MA, Overton HN, Wang P. Overprescribing is major contributor to opioid crisis. BMJ 2017; 359: j4792
  • 12 Brat GA, Agniel D, Beam A. , et al. Postsurgical prescriptions for opioid naive patients and association with overdose and misuse: retrospective cohort study. BMJ 2018; 360: j5790
  • 13 Feinberg AE, Chesney TR, Srikandarajah S, Acuna SA, McLeod RS. ; Best Practice in Surgery Group. Opioid use after discharge in postoperative patients. Ann Surg 2018; 267 (06) 1056-1062
  • 14 Campbell WK, Sedikides C. Self-threat magnifies the self-serving bias: a meta-analytic integration. Rev Gen Psychol 1999; 3 (01) 23-43
  • 15 Clarke H, Soneji N, Ko DT, Yun L, Wijeysundera DN. Rates and risk factors for prolonged opioid use after major surgery: population based cohort study. BMJ 2014; 348: g1251
  • 16 Wittekindt D, Wittekindt C, Schneider G, Meissner W, Guntinas-Lichius O. Postoperative pain assessment after septorhinoplasty. Eur Arch Otorhinolaryngol 2012; 269 (06) 1613-1621